Patent · US Active

Methods for isolating mammalian retinal progenitor cells

US9107897B2 · kind B2 · utility

4Cited by

4References

8Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Henry Klassen · Irvine, US
Jing Yang · Cambridge, US

Key dates

Filing date	May 17, 2012
Grant date	Aug 18, 2015
Priority date	—
Expiry date	May 17, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2533/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.